GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, NR3C1, PGR, PIM1, PPARA, RELA, RORC, SRC |
10.0764 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
9.57189 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.81204 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, AXL, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
8.81204 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PPARA, PTGES, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.52221 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES |
8.17052 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MMP12, MMP2, MMP9, PGR, PIM1, PTGES, RELA, SLC6A4, SRC, TERT, XDH |
8.13456 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.87075 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.81946 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, NR3C1, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.69434 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
7.65278 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, AXL, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
7.43508 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
7.2292 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.21455 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.88173 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, NR3C1, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
6.81792 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, RELA, SRC, TERT |
6.57473 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, HSD17B3, PIM1, PPARA, PTGES, TYR, XDH |
6.39198 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
6.39198 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, XDH |
6.30077 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
6.28488 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
6.24731 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
6.19918 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, RELA, RORC, SLC6A4, SRC, TERT |
6.10145 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
6.05783 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.05783 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
6.04063 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, RELA, SLC6A4, SRC |
5.89003 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.83103 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AR, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, NR3C1, PPARA, RELA, SLC6A4, SRC |
5.73131 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
5.66864 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.0614 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.95122 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, RELA, TERT |
4.91696 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, NR3C1, PTPN1, RELA, RORC, SLC6A4, SRC, TERT |
4.8945 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.81773 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A2, SLC6A4, SRC, TYR |
4.81773 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
4.78772 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CA2, CACNA1C, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MET, MMP2, MMP9, PGR, PIM1, PPARA, RELA, RORC, SLC6A4, SRC, TERT, TYR |
4.76335 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, XDH |
4.73088 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
4.72702 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGES |
4.69257 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.67691 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.66492 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
4.64037 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, APP, AR, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, RELA, RORC, SLC6A4, SRC |
4.64037 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
4.64037 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NR3C1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
4.64037 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.62671 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
4.53429 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
4.46308 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.45189 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.44723 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
4.43983 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MMP9, PGR, PIM1, PPARA, RELA, RORC, SRC, TYR |
4.43204 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, APP, CES1, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA, TYR |
4.42844 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
4.34842 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, NR3C1, RELA, RORC, SLC6A4, SRC |
4.30779 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.20243 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
4.156 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC |
4.14258 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, XDH |
4.12508 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PTPN1, RELA, SRC, TERT, XDH |
4.10235 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, ALDH2, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.07859 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.07859 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7 |
4.02238 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT |
3.93576 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MET, PPARA, PTGES |
3.87104 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
3.8643 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.80014 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.69454 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.67873 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, APP, CYP19A1, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, PPARA, PTPN1, RELA, SRC, TERT, XDH |
3.65245 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.64598 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
3.61201 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.59894 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SLC6A4, SRC |
3.57729 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
3.53516 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.47059 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, PGR, SLC6A4, SRC |
3.46957 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CYP1B1, ESRRB, F3, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SRC, TERT |
3.41142 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, PTGES |
3.39724 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.38717 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.37955 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT |
3.36353 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, ESR1, FLT3, IGF1R, MMP2, NR3C1, RELA, SLC6A4, SRC |
3.34283 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
3.3372 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, NR3C1, RELA, RORC, SLC6A4, SRC |
3.30313 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.29173 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.25028 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
3.25028 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
3.19253 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.16009 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGES |
3.16009 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.13711 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KCNH2, KDR, NR3C1, RELA, SRC |
3.13711 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, PGR, SRC |
3.13653 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PGR, PPARA, RORC, SLC6A4, SRC |
3.12083 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1A1, CYP1B1, FABP3, KCNH2, KDR, NR3C1, RELA, SLC6A2, SLC6A4, SRC |
3.07645 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
3.06465 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.05054 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7 |
3.02109 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.96243 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
2.95479 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.9429 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
2.92444 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC |
2.90548 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CACNA1C, CYP1B1, ESR1, ESRRA, ESRRB, F3, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SLC6A4, SRC, TERT, XDH |
2.87594 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MAOA |
2.85836 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.85129 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
2.83804 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.82159 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES, TERT |
2.81884 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, APP, AR, AURKB, CDC25B, ESR1, ESR2, F3, FLT3, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, XDH |
2.7959 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.76918 |
[BP] GO:0045893 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.76478 |
[BP] GO:1903508 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.76478 |
[BP] GO:1902680 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.76353 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.75012 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.73529 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.73529 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, KDR, MAP2K1, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT, XDH |
2.70116 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.69066 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
2.66437 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, AR, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
2.64546 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, AR, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
2.63203 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.62198 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.62198 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, RELA, SRC, TERT, XDH |
2.60172 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.59141 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
2.59141 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, APP, AR, CDC25B, ESRRB, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.59141 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.55024 |
[BP] GO:0051254 |
None
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.54996 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, APP, AR, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.53484 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.52696 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.52696 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.51599 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.51056 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, APP, AR, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
2.48974 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, NR3C1, RELA, SRC |
2.48264 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.47781 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.46054 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.44608 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.44608 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44608 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.42202 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APP, AR, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, MAP3K7, NR3C1, NR3C2, PGR, PPARA, RELA, RORC, TERT, TYR, XDH |
2.41579 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MAP2K1, MMP12, MMP9, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.39829 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APP, CACNA1C, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.39673 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2C19, MAOA |
2.37531 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.36347 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.35857 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
2.34785 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.3376 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SRC, TERT, XDH |
2.33757 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.32164 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, APP, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
2.31309 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.31309 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.29078 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.28803 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.28582 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.28582 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23001 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.21784 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, KCNH2, MET |
2.21031 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.21031 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.21031 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21031 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, APP, AR, CDC25B, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.21031 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20578 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.2052 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19544 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, APP, AR, CDC25B, CSNK2A1, ESR1, F3, FLT3, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
2.1937 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.16448 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, MMP9, PTPN1, RELA, SRC, TERT |
2.16448 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.16173 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.1547 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SRC |
2.1491 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, PTGES, TYR |
2.14772 |
[BP] GO:0009058 |
None
|
ACHE, AKR1B1, ALOX5, AR, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAP3K7, NR3C1, NR3C2, PGR, PPARA, PTGES, RELA, RORC, SLC6A4, TERT, TYR |
2.135 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.13009 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.12894 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.12894 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SLC6A4, SRC, TERT |
2.12591 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.12591 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.12483 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, ESR1, PGR, SLC6A4, SRC |
2.11878 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, NR3C1, RELA, SRC |
2.09808 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, AR, CYP19A1, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RELA, SRC, TERT, XDH |
2.07652 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, KCNH2, MAP2K1, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.06244 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.05024 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.0392 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.0392 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.03544 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.03544 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, CA2, CYP1A1, MMP2, PPARA, RELA, SLC6A4, SRC, TERT, TYR |
2.02284 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.41142 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTGES, PTPN1, RELA, SLC6A4, SRC, TERT, TYR, XDH |
3.13711 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, HSD11B1, HSD17B2, HSD17B3, NR3C2, PTGES, PTPN1 |
2.6226 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.91227 |
[CC] GO:0005783 |
None
|
APP, CA4, CES1, CES2, CYP19A1, FLT3, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
1.72554 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
15.851 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
10.7885 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
10.5501 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, NR3C2, PGR, RORC, SHBG |
10.5501 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
8.13456 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
8.13456 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC |
7.79991 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, F3, FLT3, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, SRC, TERT, TYR, XDH |
7.43508 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.83864 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
6.80737 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.49754 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC, SHBG |
6.39198 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7 |
6.18525 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
5.06788 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.64037 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, PGR, RELA, SLC6A4, TERT, TYR, XDH |
4.21188 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, AOX1, XDH |
4.02238 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.9865 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.9865 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1, SHBG |
3.9865 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.93142 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, PTGES, SRC, XDH |
3.86453 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.76109 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.73827 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.6552 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.61201 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.4796 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.47059 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
3.47059 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.41712 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.41142 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.4053 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.36486 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SLC6A4, SRC |
3.35219 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.34922 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.3372 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.29173 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
3.21175 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.13711 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, ESR1, ESR2, ESRRB, F3, KCNH2, MET, NR3C1, PGR, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.08617 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.08617 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RELA, RORC |
3.01328 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.99288 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.98929 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RELA, RORC |
2.88066 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.84016 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.82159 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADRA2A, ALDH2, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SLC6A4, SRC, TERT, XDH |
2.81825 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.75822 |
[MF] GO:0001047 |
None
|
ESR1, ESR2, ESRRB, MMP12, NR3C1, RELA |
2.59198 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.53445 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
2.51056 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.44608 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.44608 |
[MF] GO:0001077 |
None
|
AR, ESR1, ESRRA, NR3C1, PGR, PPARA, RELA |
2.41666 |
[MF] GO:0043565 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, NR3C2, PGR, PPARA, RELA, RORC, TERT |
2.3869 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.38439 |
[MF] GO:0001012 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PPARA, RELA, RORC |
2.34785 |
[MF] GO:0000977 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PPARA, RELA, RORC |
2.34785 |
[MF] GO:0000982 |
None
|
AR, ESR1, ESRRA, NR3C1, PGR, PPARA, RELA, RORC |
2.26984 |
[MF] GO:0001228 |
None
|
AR, ESR1, ESRRA, ESRRB, NR3C1, PGR, PPARA, RELA |
2.21031 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21031 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.21031 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ALDH2, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
2.1849 |
[MF] GO:0044212 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, PGR, PPARA, RELA, RORC |
2.05464 |
[MF] GO:0001067 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, PGR, PPARA, RELA, RORC |
2.05174 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.0392 |
[MF] GO:0000976 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PPARA, RELA, RORC |
2.00533 |